Bank of Nova Scotia Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,355
| Closed | -$239K | – | 137 |
|
|
2022
Q3 | $239K | Buy |
3,355
+650
| +24% | +$47.2K | 0.03% | 123 |
|
|
2022
Q2 | $209K | Buy |
+2,705
| New | +$206K | 0.02% | 126 |
|
|
2021
Q3 | – | Sell |
-3,502
| Closed | -$234K | – | 142 |
|
|
2021
Q2 | $234K | Buy |
3,502
+2
| +0.1% | +$130 | 0.02% | 130 |
|
|
2021
Q1 | $221K | Buy |
3,500
+2
| +0.1% | +$124 | 0.02% | 131 |
|
|
2020
Q4 | $217K | Sell |
3,498
-2
| -0.1% | -$123 | 0.02% | 127 |
|
|
2020
Q3 | $211K | Hold |
3,500
| – | – | 0.03% | 115 |
|
|
2020
Q2 | $206K | Buy |
+3,500
| New | +$209K | 0.03% | 100 |
|
|
2020
Q1 | – | Sell |
-3,550
| Closed | -$228K | – | 109 |
|
|
2019
Q4 | $228K | Sell |
3,550
-394
| -10% | -$22.6K | 0.03% | 107 |
|
|
2019
Q3 | $200K | Buy |
+3,944
| New | +$185K | 0.02% | 114 |
|
|
2019
Q1 | – | Sell |
-3,950
| Closed | -$205K | – | 123 |
|
|
2018
Q4 | $205K | Hold |
3,950
| – | – | 0.03% | 109 |
|
|
2018
Q3 | $245K | Sell |
3,950
-100
| -2% | -$5.93K | 0.03% | 112 |
|
|
2018
Q2 | $224K | Hold |
4,050
| – | – | 0.03% | 113 |
|
|
2018
Q1 | $256K | Hold |
4,050
| – | – | 0.03% | 109 |
|
|
2017
Q4 | $248K | Sell |
4,050
-1,402
| -26% | -$87.7K | 0.03% | 114 |
|
|
2017
Q3 | $348K | Buy |
5,452
+1,502
| +38% | +$87.7K | 0.04% | 104 |
|
|
2017
Q2 | $220K | Hold |
3,950
| – | – | 0.03% | 116 |
|
|
2017
Q1 | $215K | Buy |
3,950
+10
| +0.3% | +$548 | 0.02% | 116 |
|
|
2016
Q4 | $230K | Hold |
3,940
| – | – | 0.03% | 105 |
|
|
2016
Q3 | $212K | Hold |
3,940
| – | – | 0.03% | 109 |
|
|
2016
Q2 | $290K | Hold |
3,940
| – | – | 0.04% | 95 |
|
|
2016
Q1 | $252K | Hold |
3,940
| – | – | 0.03% | 96 |
|
|
2015
Q4 | $271K | Hold |
3,940
| – | – | 0.04% | 94 |
|
|
2015
Q3 | $233K | Sell |
3,940
-15
| -0.4% | -$952 | 0.03% | 109 |
|
|
2015
Q2 | $267K | Hold |
3,955
| – | – | 0.03% | 108 |
|
|
2015
Q1 | $255K | Hold |
3,955
| – | – | 0.03% | 105 |
|
|
2014
Q4 | $233K | Hold |
3,955
| – | – | 0.03% | 106 |
|
|
2014
Q3 | $202K | Buy |
+3,955
| New | +$198K | 0.02% | 117 |
|
|
2014
Q2 | – | Sell |
-3,955
| Closed | -$205K | – | 122 |
|
|
2014
Q1 | $205K | Hold |
3,955
| – | – | 0.03% | 115 |
|
|
2013
Q4 | $210K | Buy |
+3,955
| New | +$201K | 0.03% | 111 |
|
Other funds holding BMY
AWA
Bank of Nova Scotia Trust's BMY Position: Q4 2022 in Review
Bank of Nova Scotia Trust sold out of Bristol-Myers Squibb (BMY) in Q4 2022, closing a stake of 3,355 shares — an estimated $239K sold.
Bank of Nova Scotia Trust first reported a position in BMY in Q4 2013 and held it in 29 quarters. The position peaked at $348K in Q3 2017. 2,601 funds tracked by Wall St. Rank hold BMY as of Q4 2022.
- Bank of Nova Scotia Trust reported no remaining Bristol-Myers Squibb position as of Q4 2022 after selling out during the quarter.
- Bank of Nova Scotia Trust sold 3,355 Bristol-Myers Squibb shares in Q4 2022, an estimated $239K.
- Bank of Nova Scotia Trust first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 29 quarters.
- Bank of Nova Scotia Trust's Bristol-Myers Squibb position peaked at $348K in Q3 2017.
- 2,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.
Based on Bank of Nova Scotia Trust's 13F filing for Q4 2022, filed 9 Feb 2023.